Merck

Merck commits to sharing study protocols

Tuesday, July 5, 2011 12:24 PM

Merck will voluntarily include the research protocol and statistical analysis plan among the materials it supplies to medical journals when it submits clinical study manuscripts for publication, according to a PharmaTimes report.

More... »

Merck signs HCV agreement with Roche

Wednesday, May 18, 2011 12:05 PM

Merck and Roche have signed a pact to sell Merck’s recently approved hepatitis C drug Victrelis and explore combination treatments for the disease.

More... »

Merck plans to close Inspire headquarters and cut jobs

Tuesday, May 17, 2011 12:31 PM

With Merck’s purchase of Inspire Pharmaceuticals comes jobs cuts, relocation, and the closing of  Inspire headquarters in North Carolina. It's unclear how many jobs will be cut, but senior Inspire executives are preparing to leave, the News & Observer reports.

More... »

Merck’s Victrelis approved by FDA

Monday, May 16, 2011 12:50 PM

Merck’s new hepatitis C drug Victrelis has received FDA approval according to Pharma Times. The approval is based on two phase III trials with 1,500 adults.

More... »

FDA finds Vertex’s HVC drug effective

Wednesday, April 27, 2011 01:48 PM

The FDA has indicated that Vertex Pharmaceuticals’ experimental drug telaprevir cures more patients of hepatitis C than any current therapies, according to a Bloomberg report. 

More... »

Merck moves into Africa

Tuesday, April 26, 2011 12:49 PM

Merck is taking an emerging-markets approach to its business strategies and will expand marketing in Africa, company chairman Frank Stangenberg-Haverkamp reported in Johannesburg, according to FiercePharma.

More... »

Merck and Sun sign pact

Tuesday, April 26, 2011 11:41 AM

Merck and India-based Sun Pharmaceutical Industries have collaborated regarding rights to Merck’s diabetes drug Januvia, according to Pharma Times.

More... »

Report: Some sponsors more prepared to lead the way in personalized medicine than others

Monday, April 18, 2011 08:05 AM

As the pharmaceutical industry’s investment in personalized medicine leads to development of an increasing number of targeted therapies, particularly for cancer patients, some drug sponsors have shown greater commitment and more structure in their approach than others, according to a new report by consulting firm Diaceutics.

More... »

Shanghai Pharmaceuticals inks $3 billion in overseas contracts

Thursday, April 14, 2011 01:07 PM

Shanghai Pharmaceuticals will ink more than $3.06 billion worth of procurement contracts with 69 worldwide pharmaceutical companies this year, according to Global Times.

More... »

Merck to cut jobs

Wednesday, April 13, 2011 01:16 PM

Merck is cutting production and staff at their Riverside, Pa. manufacturing plant.  The company plans to outsource some work and sell the plant's fermentation operations, according to Fierce Pharma.

More... »